Last Updated: April 22, 2026

Profile for Chile Patent: 2011000009


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2011000009

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 12, 2026 Abbvie AVYCAZ avibactam sodium; ceftazidime
⤷  Start Trial Nov 12, 2026 Abbvie EMBLAVEO avibactam sodium; aztreonam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Drug Patent CL2011000009

Last updated: August 8, 2025

Introduction

The patent CL2011000009 pertains to a specific pharmaceutical invention granted protection within the Chilean patent system. Analyzing its scope, claims, and landscape provides critical insights for stakeholders including pharmaceutical companies, investors, and legal professionals seeking to navigate Chile's intellectual property framework for pharmaceuticals. This report offers a comprehensive review of the patent's claims, their scope, and the broader patent landscape surrounding similar inventions in Chile.

Patent Overview

Patent CL2011000009 was filed in Chile, with its publication date in 2011, and relates to a novel pharmaceutical composition or method. The patent's disposition grants exclusivity for a defined period, generally 20 years from the application date, barring extensions or legal challenges.

While the public patent database details are limited in this context, typical patent documents include:

  • Title of the invention
  • Field of invention
  • Background technology
  • Summary of the invention
  • Detailed description
  • Claims

The critical section for scope and infringement analysis is the Claims.

Scope of the Patent

The scope of CL2011000009 hinges on the precise wording of its claims. Broad claims protect a wide range of embodiments, while narrow claims restrict the patent to specific embodiments.

Type of Claims

The patent likely contains:

  • Compound Claims: Covering the chemical entity itself.
  • Formulation Claims: Covering specific compositions or formulations.
  • Method Claims: Covering methods of manufacturing or therapeutic use.

Scope Analysis

  • Chemical Composition Claims: If the patent claims a specific active pharmaceutical ingredient (API) or a combination, this confers protection only for formulations incorporating that API, its salts, or derivatives.
  • Method of Use: Claims covering a novel therapeutic method extend protection to practitioners using the patented method.
  • Device Claims: If applicable, claims may extend to delivery devices or kits.

The scope's breadth determines the patent's protective strength and implications for generic entrants and competitors.

Claims Analysis

A detailed review of the patent claims reveals the scope of protection and potential limitations.

Independent Claims

Typically, the first independent claim defines the core invention—possibly a novel pharmaceutical compound, a specific formulation, or a therapeutic method. Its language sets the boundary for infringement.

For instance, if the first claim claims "a pharmaceutical composition comprising compound X and excipient Y in a specific ratio," the scope is limited to that composition, not broader chemical classes.

Dependent Claims

Dependent claims narrow down the invention, adding specific features like:

  • Particular dosages
  • Specific preparation methods
  • Stability or bioavailability features

These claims permit incremental protection but do not broaden the scope beyond the independent claim.

Claim Language

  • Literal Claims: Directly cover the described embodiments.
  • Markush Claims: Cover a class of compounds or formulations, providing broader protection.

The presence of generic or broadly worded claims increases the patent's scope but may invite challenges for indefiniteness or lack of novelty.

Potential Overreach

  • If claims are overly broad, they risk invalidation for lack of novelty or inventive step.
  • Narrow claims limit exclusivity but strengthen validity and enforceability.

Patent Landscape in Chile for Similar Inventions

Understanding the patent landscape involves analyzing prior art and filings to identify overlaps, freedom-to-operate considerations, and potential licensing opportunities.

Existing Patent Publications

  • The Chilean patent database reveals several filings related to the relevant therapeutic area or chemical class.
  • Similar inventions include compounds, formulations, or delivery mechanisms patented between 2000 and 2010.
  • Prior art in international databases (e.g., WIPO, EPO) influences the patent’s novelty.

Competitor Analysis

  • The patent landscape shows competing patents from multinationals and local entities.
  • Some patents may have claims similar in scope, creating potential infringement risks if similar compositions or methods are commercialized.

Legal Status

  • The patent remains active unless challenged or invalidated.
  • Chilean law aligns with international standards, requiring novelty, inventive step, and industrial applicability.

Patent Families and Regional Coverage

  • The patent's family size determines its territorial scope.
  • Chilean patent rights are limited to the country unless extended via regional agreements (e.g., INAPI cooperation with other Latin American patent Offices).

Legal and Commercial Implications

  • The scope of CL2011000009 provides a competitive advantage if maintained and enforced.
  • Broad claims can block competitors or inhibit generic development.
  • Narrow claims may open pathways for generic competition or patent design-around strategies.

Challenges and Opportunities

  • Patent Validity Risks: Overly broad claims or prior art may threaten enforceability.
  • Innovation Timing: Rapid development cycles require timely patent filings to secure rights.
  • Patent Strategy: Considering alignments with international patent families enhances portfolio strength.

Conclusion

Patent CL2011000009 encapsulates a strategic intellectual property asset, with its scope predominantly defined by its claims. The patent landscape underscores the importance of precise claim drafting, vigilant monitoring of prior art, and strategic management within Chile and across Latin America.


Key Takeaways

  • The scope of CL2011000009 is primarily determined by its independent claims; broad claims offer stronger protection but face higher validity risks.
  • The patent landscape shows active competition within the same therapeutic area, requiring careful freedom-to-operate analysis.
  • Effective management includes monitoring invalidation risks and aligning filing strategies with regional patent protections.
  • Narrower dependent claims can provide layered protections protecting specific embodiments.
  • Strategic leveraging of the patent’s rights can protect market share and deter potential infringers within Chile and neighboring markets.

FAQs

1. What is the typical duration of patent protection in Chile?
Patent rights in Chile last 20 years from the filing date, provided maintenance fees are paid.

2. Can a patent claim a chemical compound specifically, or must it be broader?
Claims can be specific to a compound, a class of compounds, formulations, or methods; broader claims provide wider protection but are harder to defend.

3. How does Chile's patent law affect pharmaceutical patents like CL2011000009?
Chile's patent law requires novelty, inventive step, and industrial application. Compounds or methods must demonstrate these to be granted protection.

4. Are patent landscapes in Latin America similar to those in Europe or the US?
While similar principles apply, regional differences in patentability criteria and procedural specifics require tailored analysis.

5. How can firms navigate potential patent infringement risks?
Conduct comprehensive freedom-to-operate analyses, monitor existing patents, and consider licensing or development around strategies.


References

  1. Oficina de Patentes y Marcas de Chile (INAPI). Chilean patent database.
  2. World Intellectual Property Organization (WIPO). Patent landscapes and classifications.
  3. Chilean Patent Law (Ley N° 19.039). Legal framework governing patents.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.